Irisin as a Novel Marker for Insulin Resistance in Iraqi Women with Polycystic Ovary Syndrome Before and After Metformin Therapy

@article{Farhan2018IrisinAA,
  title={Irisin as a Novel Marker for Insulin Resistance in Iraqi Women with Polycystic Ovary Syndrome Before and After Metformin Therapy},
  author={Fatin Shallal Farhan and Shatha Sami Hussien},
  journal={The Journal of Obstetrics and Gynecology of India},
  year={2018},
  pages={1-7}
}
BackgroundPolycystic ovarian syndrome affects 5–10% of women; it represents the most common cause of hyperinsulinemia with anovulation. Many biomarkers are used to assess insulin resistance. Irisin is a newly discovered myokine associated with insulin resistance and other metabolic syndromes.ObjectiveTo measure the serum level of irisin in polycystic ovary syndrome patients and assess the effect of metformin treatment on its level.MethodThis study was a prospective interventional study… CONTINUE READING